MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karkanias, G. B.
Right arrow Articles by Etgen, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karkanias, G. B.
Right arrow Articles by Etgen, A. M.

Estradiol reduction of the agonist high affinity form of the alpha 2- adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype

GB Karkanias and AM Etgen

Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461.

These studies examined which alpha 2-adrenoceptor subtype is expressed in the hypothalamus and preoptic area and the influence of estradiol administration on alpha 2-adrenoceptors in the hypothalamus of female rats. The alpha 2-adrenoceptor antagonist [3H] RX821002 bound to a single site in hypothalamus, preoptic area, and cortex membranes, with high affinity and low nonspecific binding, as determined by Scatchard and kinetic binding analyses. Competition for [3H]RX821002 binding in the hypothalamus and preoptic area by various noradrenergic agonists and antagonists revealed a unique pharmacological specificity with a high degree of similarity to that of the alpha 2D-adrenoceptor. Norepinephrine displacement of [3H]RX821002 binding in hypothalamic membranes from ovariectomized animals was monophasic and characterized by high affinity. In contrast, norepinephrine competition for [3H]RX821002 binding sites in the hypothalamus from rats exposed to estradiol for 48 hr was biphasic, and norepinephrine bound to both a high (18%) and a low (82%) affinity site in these membranes. Thus, the formation of agonist high affinity alpha 2D-adrenoceptor complexes was inhibited by prior exposure to estrogen. In both control and estradiol- exposed hypothalamic membranes, 100 microM 5'-guanylylimidodiphosphate [Gpp(NH)p] converted the norepinephrine competition curves to ones characterized by monophasic, low affinity binding. In addition, binding of the full alpha 2-adrenoceptor agonist [3H]UK-14,304 in the hypothalamus and preoptic area of female rats was concentration- dependently diminished by Gpp(NH)p treatment. Complete loss of [3H]UK- 14,304 binding was effected by 100 microM Gpp(NH)p. This suggests that [3H]UK-14,304 may be useful in labeling the agonist high affinity state of alpha 2-adrenoceptors. Decreasing the incubation temperature in saturation studies from 25 degrees to 0 degrees increased [3H]UK-14,304 binding in hypothalamic membranes of control rats but not in membranes from estradiol-treated rats. Estradiol treatment for 48 hr decreased [3H]UK-14,304 binding in hypothalamic membranes by 34% (0 degrees) to 60% (25 degrees), without changing the Kd. These results suggest that the alpha 2D-adrenoceptor is the predominant subtype in the hypothalamus and preoptic area of female rats and that estradiol treatment markedly reduces the number of alpha 2D-adrenoceptors in the agonist high affinity state.

Volume 45, Issue 3, pp. 509-516, 03/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
HypertensionHome page
Y. Zhang and S. T. Davidge
Effect of Estrogen Replacement on Vasoconstrictor Responses in Rat Mesenteric Arteries
Hypertension, November 1, 1999; 34(5): 1117 - 1122.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. J. Morris and C. C. Malbon
Physiological Regulation of G Protein-Linked Signaling
Physiol Rev, October 1, 1999; 79(4): 1373 - 1430.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. A. Ansonoff and A. M. Etgen
Estradiol Elevates Protein Kinase C Catalytic Activity in the Preoptic Area of Female Rats
Endocrinology, July 1, 1998; 139(7): 3050 - 3056.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. J. Mills, R. A. Nelesen, M. G. Ziegler, B. L. Parry, C. C. Berry, E. Dillon, and J. E. Dimsdale
Menstrual Cycle Effects on Catecholamine and Cardiovascular Responses to Acute Stress in Black but Not White Normotensive Women
Hypertension, April 1, 1996; 27(4): 962 - 967.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics